Portea Medical Expands Cancer Care Services Across India

New Delhi, August 6, 2025 — Portea Medical, India’s leading home healthcare provider, has announced the nationwide expansion of its comprehensive cancer care services. The initiative aims to ease access for oncology patients by offering treatment, monitoring, and palliative care at home — a significant relief for patients undergoing chemotherapy, radiotherapy, and post-treatment support.

This move comes as India witnesses a sharp rise in cancer cases. The need for decentralized, home-based services is more urgent than ever. According to the Indian Council of Medical Research (ICMR), India is projected to witness over 15 lakh new cancer cases in 2025. Many patients, particularly those in Tier 2 and Tier 3 cities, lack access to continuous, affordable, and high-quality cancer care.

Services Now Offered Across Cities

Portea Medical will now provide services in Delhi NCR, Bengaluru, Hyderabad, Chennai, Mumbai, and several smaller towns. These include:

  • Chemotherapy and medication administration

  • IV infusions and wound care

  • Nutrition counseling

  • Pain management

  • Oncologist-led virtual consultations

  • Emotional support and palliative care

The model has been piloted over the last year and, after positive outcomes and feedback, is now being scaled up.

Why It Matters

Cancer treatment is often long, exhausting, and disruptive. Families face financial and emotional stress. Traveling to hospitals multiple times weekly is painful — especially for terminally ill or elderly patients.

Home-based models are known to improve treatment compliance, reduce hospital-acquired infections, and help patients maintain dignity during advanced stages.

Dr. Vishal Sehgal, President of Portea Medical, said, “We want to bring compassionate care to patients’ doorsteps. Cancer is not just a medical battle — it’s a mental and emotional journey. Our teams are trained to support families throughout.”

Dr. Rajesh Chopra, senior oncologist at Max Healthcare, welcomed the initiative. “This aligns with global standards where home infusion therapy and palliative care are integral. India needs more such models, particularly in semi-urban regions.”

While India’s National Cancer Grid and public hospitals have expanded infrastructure, access remains unequal. Tele-oncology and home health tech platforms are being seen as the next wave in patient-centered cancer treatment.

According to Frost & Sullivan, India’s home healthcare market is expected to reach ₹7,000 crore by 2026, driven largely by chronic diseases like cancer, diabetes, and heart conditions.

Portea Medical’s initiative is expected to serve over 20,000 oncology patients in the next 12 months.

For full details, visit: medicarepharmabusiness.com

Related Posts

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus board approved a buyback of up to Rs 1100 crore at Rs 1,150 per share, along with a 100 percent dividend for FY26. Zydus Lifesciences reported a rise in…

Chemists strike on May 20: Reasons behind today’s all-India strike

While major pharmacy chains and government medical outlets will remain operational, the strike highlights significant tensions within the industry that could impact access to medications nationwide. The All India Organisation…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus Lifesciences Q4FY26 net profit rises 9%

Chemists strike on May 20: Reasons behind today’s all-India strike

Chemists strike on May 20: Reasons behind today’s all-India strike

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug

GSK’s Calpol a well-known trademark: High Court

GSK’s Calpol a well-known trademark: High Court

3 arrested for allegedly posing as doctors using forged MBBS degrees

3 arrested for allegedly posing as doctors using forged MBBS degrees

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures